ICA-27243
CAS: 325457-89-4
Ref. 3D-ANA45789
10mg | Descontinuado | ||
25mg | Descontinuado | ||
50mg | Descontinuado | ||
100mg | Descontinuado | ||
250mg | Descontinuado |
Informação sobre produto
ICA-27243 is a positive allosteric modulator of the M2 subtype of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor. It has been shown to be effective in reducing symptoms of Parkinson's disease and has also been shown to have neuroprotective properties in vivo. ICA-27243 is a drug that is being developed for the treatment of Parkinson's disease, with clinical trials showing an improvement in motor function, including reduced symptoms and reduced dopamine depletion. It has also been shown to be beneficial in other conditions such as depression, anxiety, and schizophrenia.